Whereas metastatic castrate-resistant prostate cancer used to have a poor prognosis, new agents are available and continuing to emerge with the potential to extend survival, but there is no ...
Recently, licensed and emerging treatments for metastatic ... a view to maximize survival as well. This article provides an overview of developments in advanced prostate cancer and considers ...
Sheel Patel, a board certified physician in hematology, oncology, and internal medicine, spoke with Healthline about how prostate cancer affects Black men, including rate of diagnosis, survival ...
The report, covering 2020 to 2022, examines cancer incidence and survival rates. It looks at the four most common forms of the disease in Ireland: lung, bowel, breast and prostate cancers.
“Progression-free survival outcomes with nivolumab plus ipilimumab were superior to those with chemotherapy in the first-line treatment of MSI-H or dMMR metastatic colorectal cancer,” the ...